
|Articles|February 19, 2016
Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach
Author(s)DIA
Advertisement
After ten years of successive minority and/or majority Conservative leadership, Canada is now led by Prime Minister Justin Trudeau’s Liberal majority. A key component of the Liberal platform is the creation of a Chief Science Officer position to ensure that “scientific analyses are considered when the government makes decisions”; this renewed focus on evidence-based policy may be helpful to science-based industries across a number of sectors.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
2
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape
5




